Scientific Program - ESR Annual Meeting 2025

Scientific Program

07:30 – 15:00Registration
08:30 – 09:50Session 1: CAR T & Artificial Intelligence
08:30 – 08:50Keynote Lecture: Adopting New Artificial Intelligence (AI) Trends to Reshape Rheumatology PracticeDr. Thomas Hügle
08:50 – 09:20Making Sense of CAR T in Autoimmune ConditionsDr. Chris Wincup
09:20 – 09:40CAR T in Lupus – UAE ExperienceDr. Tahir Khan
09:40 – 09:50Q&A & Certificates
09:50- 10:10Opening Ceremony
10:10 – 10:40Industry Symposium
10:40 – 10:55Coffee Break
10:55 – 12:25Session 2: What is New . WIN
10:55 – 11:20Everything you Need to Know About GLP-1 Receptor Agonists and SGLT-2 InhibitorsDr. Elamin Abdelgadir
11:20 – 11:45Bridging Gaps in JAKi Use Beyond ArthritisDr. Daniel Furst
11:45 – 11:55Q&A & Certificates
11:55 – 12:25Industry Symposium
12:25 – 13:40Lunch
13:40 – 15:10Session 3: Systemic Lupus Erythematosus (SLE) / Antiphospholipid Syndrome (APS)
13:40 – 14:00Lupus Nephris Under the Lens: What’s New? What’s Next?Dr. Oseme Etome
14:00 – 14:20Pitfalls of the 2023 ACR/EULAR Antiphospholipid Syndrome (APS) Classification CriteriaProf. Munther Khamashta
14:20 – 15:00Decoding Systemic Lupus Erythematosus (SLE) / Antiphospholipid Syndrome (APS) in PregnancyDr. Oseme Etome
15:00 – 15:10Q&A & Certificates
15:10 – 16:10Session 4: Rheumatoid Arthritis (RA)
15:10 – 15:35Cracking the Code of Difficult-to-Treat RADr. Daniel Furst
15:35 – 16:00Infection in Rheumatic Conditions: Use of immunomodulators in HIV infectionDr. Aqeel Salem
16:00 – 16:10Q&A & Certificates
16:10 – 16:40Industry Symposium
16:40 – 16:55Coffee Break
16:55 – 18:00Session 5: Neoplasia and Rheumatology
16:55 – 17:20Check it Out! What is New in Check Point Inhibitors in RheumatologyDr. Chris Wincup
17:20 – 17:50
  • 2024 EULAR Points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
  • DMARDs and Malignancy. Cancer Screening, EULAR Guidance and Beyond
Dr. Ahmed Zayat
17:50 – 18:00Q&A & Certificates
16:10 – 16:40Industry Symposium

END OF DAY 3

*Disclaimer: Preliminary Agenda as of 22 September 2025, subject to potential modifications without prior notification.

07:30 – 15:00Registration
09:50 – 10:00Welcome Remarks
10:00 – 11:45Pediatric Session 1
10:00 – 10:35Systemic Lupus Erythematosus and monogenic Lupus: Best Practices for Pediatric PatientsDr. Sulaiman Almayouf
10:35 – 11:10Approach to variant of unknown significance interpretation in SLEDr. Adnan AlAli
11:10 – 11:45Atypical Presentations of Juvenile SLEDr. Reem Abdawani
11:45 – 12:00Coffee Break
12:00 – 13:45Pediatric Session 2
12:00 – 12:35Vasculitis in Children: Diagnosis, Management, and Long-Term OutcomesDr. Buthaina Al Athba
12:35 – 13:10Optimizing the Transition from Pediatric to Adult Care: An Expert OpinionDr. Elsadeg Sharif
13:10 – 13:45Targeting the JAK–STAT Pathway in Monogenic Interferonopathies: Clinical Advances and ChallengesDr. Shima Kamal
12:25 – 13:40Lunch

END OF DAY

*Disclaimer: Preliminary Agenda as of 15 September 2025, subject to potential modifications without prior notification.

REGISTER NOW